AcelRx Pharmaceuticals Inc. | TalkMarkets

Article By: Elle Investments

Tuesday, May 26, 2020 1:12 PM EDT

Sales of sublingual sufentanil tablet Dsuvia have been slow out of the gate, but we remain very bullish on the long-term prospects.

In this article: ACRX

Article By: TipRanks

Wednesday, October 24, 2018 4:58 AM EDT

Biotech stocks can soar or plunge depending on FDA decisions. There’s no doubt that buying ahead of PDUFA dates is a risky call.

In this article: ACRX, CPRX Also: TXMD, OCUL

Article By: Rod Raynovich

Friday, September 16, 2016 1:44 AM EDT

Traders “whipsawed” biotech stocks but still the IBB managed to hold onto short-term gains of 10 points over the intermediate support of $280.

In this article: AGN, BMY, ACRX, IBB, AMGN, GILD, XBI, VTAE, BLUE, AERI

Article By: TipRanks

Thursday, July 2, 2015 9:16 AM EDT

Thursday Morning Pre-Market Insights: Centene Corp, BreitBurn Energy Partners, L.P., Fitbit Inc. and AcelRx Pharmaceuticals, Inc.

In this article: ACRX, BBEP, CNC, FIT